Loading clinical trials...
Loading clinical trials...
30-day, Single-arm Study of the Safety, Efficacy and the Pharmacokinetic and Pharmacodynamic Properties of Oral Rivaroxaban in Children With Various Manifestations of Venous Thrombosis
Conditions
Interventions
Rivaroxaban (Xarelto, BAY59-7939)
Active comparator
+1 more
Locations
59
United States
Little Rock, Arkansas, United States
Los Angeles, California, United States
Orange, California, United States
Chicago, Illinois, United States
Indianapolis, Indiana, United States
Detroit, Michigan, United States
Start Date
February 19, 2013
Primary Completion Date
September 1, 2016
Completion Date
September 1, 2016
Last Updated
September 21, 2017
NCT06650826
NCT05588284
NCT03050671
NCT05171075
NCT06913595
NCT02318472
Lead Sponsor
Bayer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions